Health outcomes | Cost* | Incremental cost | Effectiveness | Incremental effectiveness | Incremental cost- effectiveness ratio (ICER) | |
---|---|---|---|---|---|---|
 | No discounting | Discounting 3% | ||||
Incidence of ALRI/1000-person years | ||||||
  < 1 year of age | ||||||
  Intervention | 36.35 | 29.7 | 154.6 | −46.6 | Dominated | Dominated |
  Vaccinated | 34.0 | 27.39 | 154.5 | −46.5 | Dominated | Dominated |
  Control | 6.6 |  | 108.0 |  |  |  |
  > 1 year of age | ||||||
  Intervention | 29.3 | 26.4 | 56.4 | 3.96 | 6.7 | 7.5 |
  Vaccinated | 28.7 | 25.9 | 30.6 | 29.8 | 0.9 | 1.0 |
  Control | 2.83 |  | 60.4 |  |  |  |
  > 2 years of age | ||||||
  Intervention | 28.3 | 25.8 | 26.1 | 3.5 | 7.3 | 9.7 |
  Vaccinated | 28.7 | 26.2 | 22.8 | 6.8 | 0.26 | 3.1 |
  Control | 2.5 |  | 29.6 |  |  |  |
 Total follow-up period | 27 |  |  |  |  |  |
  Intervention | 39.7 | 28.1 | 88.5 | −13.3 | Dominated | Dominated |
  Vaccinated | 39.5 | .9 | 82.1 | −7.0 | Dominated | Dominated |
  Control | 11.6 |  | 75.2 |  |  |  |